Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy

By sjmartinez • March 7, 2024

Everett EM. Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy. JAMA Netw Open. 2024 Mar 4;7(3):e240718. doi: 10.1001/jamanetworkopen.2024.0718. PMID: 38446485.

Tags: Endocrinology, General Internal Medicine, Publications, Veterans Administration

A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors

Mogar N, Zhang D, Heaney AP. A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors. Int J Mol Sci. 2025 Jun 19;26(12):5898.[...]

Metabolic Messengers: oestradiol

Hevener AL, Correa SM. Metabolic Messengers: oestradiol. Nat Metab. 2025 Jun;7(6):1114-1122. doi: 10.1038/s42255-025-01317-7. Epub 2025 Jun 24. PMID: 40562968.

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]